{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:33:21Z","timestamp":1777901601235,"version":"3.51.4"},"reference-count":89,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bprclinrheum.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.berh.2016.03.004","type":"journal-article","created":{"date-parts":[[2016,5,29]],"date-time":"2016-05-29T11:15:58Z","timestamp":1464520558000},"page":"22-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Connective tissue disease-related pulmonary arterial hypertension"],"prefix":"10.1016","volume":"30","author":[{"given":"Vivek","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund M.T.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2016.03.004_bib1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Galie","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2016.03.004_bib2","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2016.03.004_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1183\/09059180.00008211","article-title":"REVEAL: a contemporary US pulmonary arterial hypertension registry","volume":"21","author":"McGoon","year":"2012","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.berh.2016.03.004_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era","volume":"179","author":"Condliffe","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.berh.2016.03.004_bib5","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.berh.2016.03.004_bib6","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/art.24525","article-title":"The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France","volume":"60","author":"Hachulla","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.03.004_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.semarthrit.2014.03.002","article-title":"Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS) cohort study","volume":"44","author":"Hsu","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.03.004_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1183\/09059180.00003811","article-title":"Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus","volume":"20","author":"Johnson","year":"2011","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.berh.2016.03.004_bib9","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/art.38029","article-title":"Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis","volume":"65","author":"Lefevre","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.03.004_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/ar4051","article-title":"Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study","volume":"14","author":"Ngian","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2016.03.004_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/acr.22121","article-title":"Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry","volume":"66","author":"Chung","year":"2014","journal-title":"Arthritis Care Res Hob"},{"key":"10.1016\/j.berh.2016.03.004_bib12","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.30541","article-title":"Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival","volume":"63","author":"Humbert","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.03.004_bib13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.03.004_bib14","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.03.004_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0000000000000027","article-title":"Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies","volume":"26","author":"Nikpour","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2016.03.004_bib16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/rheumatology\/ken488","article-title":"Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study","volume":"48","author":"Hachulla","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2016.03.004_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1445-5994.2011.02624.x","article-title":"Screening and treating pulmonary arterial hypertension in a tertiary hospital-based multidisciplinary clinic: the first 200 patients","volume":"43","author":"Low","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.berh.2016.03.004_bib18","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1161\/CIRCULATIONAHA.114.006974","article-title":"Advances in therapeutic interventions for patients with pulmonary arterial hypertension","volume":"130","author":"Humbert","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2016.03.004_bib19","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.100245","article-title":"Prevalence of pulmonary hypertension in systemic sclerosis in European caucasians and metaanalysis of 5 studies","volume":"37","author":"Avouac","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.03.004_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.acvd.2009.06.009","article-title":"Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies","volume":"103","author":"Meune","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.berh.2016.03.004_bib21","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.berh.2016.03.004_bib22","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/art.34501","article-title":"Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension","volume":"64","author":"Gunther","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.03.004_bib23","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/01.CIR.80.5.1198","article-title":"Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, primary pulmonary hypertension registry","volume":"80","author":"Pietra","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2016.03.004_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/09031936.00090608","article-title":"Pulmonary veno-occlusive disease","volume":"33","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2016.03.004_bib25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e31818193bb","article-title":"Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology","volume":"87","author":"Montani","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.berh.2016.03.004_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2214\/ajr.183.1.1830065","article-title":"Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease","volume":"183","author":"Resten","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.berh.2016.03.004_bib27","first-page":"867","article-title":"From the archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis","volume":"27","author":"Frazier","year":"2007","journal-title":"Radiogr Rev Publ Radiol Soc N. Am Inc"},{"key":"10.1016\/j.berh.2016.03.004_bib28","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.humpath.2006.11.022","article-title":"Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases","volume":"38","author":"Dorfmuller","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.berh.2016.03.004_bib29","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/CIRCULATIONAHA.114.009309","article-title":"Update on chronic thromboembolic pulmonary hypertension","volume":"130","author":"Lang","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2016.03.004_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.athoracsur.2012.04.004","article-title":"Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients","volume":"94","author":"Madani","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.berh.2016.03.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2012.10.009","article-title":"Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis","volume":"26","author":"Bossone","year":"2013","journal-title":"J\u00a0Am Soc Echocardiogr Off Publ Am Soc Echocardiogr"},{"key":"10.1016\/j.berh.2016.03.004_bib32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1164\/rccm.200811-1691OC","article-title":"Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension","volume":"179","author":"Fisher","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.berh.2016.03.004_bib33","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1016\/j.ijcard.2013.07.005","article-title":"Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension","volume":"168","author":"D'Alto","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.berh.2016.03.004_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0735-1097(85)80172-8","article-title":"Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound","volume":"6","author":"Berger","year":"1985","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.berh.2016.03.004_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.echo.2015.11.001","article-title":"Addressing the controversy of estimating pulmonary arterial pressure by echocardiography","volume":"29","author":"Amsallem","year":"2016","journal-title":"J\u00a0Am Soc Echocardiogr Off Publ Am Soc Echocardiogr"},{"key":"10.1016\/j.berh.2016.03.004_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"Rudski","year":"2010","journal-title":"J\u00a0Am Soc Echocardiogr Off Publ Am Soc Echocardiogr"},{"key":"10.1016\/j.berh.2016.03.004_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrcardio.2014.191","article-title":"Early detection of pulmonary arterial hypertension","volume":"12","author":"Lau","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.berh.2016.03.004_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/ar4383","article-title":"The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study","volume":"15","author":"Thakkar","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2016.03.004_bib39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1183\/09059180.00006111","article-title":"Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening","volume":"20","author":"Denton","year":"2011","journal-title":"Eur Respir Rev Off J Eur Respir Soc"},{"key":"10.1016\/j.berh.2016.03.004_bib40","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.03.004_bib41","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2016.03.004_bib42","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2016.03.004_bib43","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/eurheartj\/ehq170","article-title":"Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension","volume":"31","author":"Montani","year":"2010","journal-title":"Eur heart J"},{"key":"10.1016\/j.berh.2016.03.004_bib44","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/eurheartj\/ehr160","article-title":"Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward","volume":"32","author":"Lau","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.berh.2016.03.004_bib45","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1378\/chest.126.1_suppl.14S","article-title":"Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"McGoon","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.berh.2016.03.004_bib46","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1002\/art.38172","article-title":"Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.03.004_bib47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imj.12691","article-title":"Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension","volume":"45","author":"Thakkar","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/j.berh.2016.03.004_bib48","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2016.03.004_bib49","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.03.004_bib50","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/rheumatology\/keh067","article-title":"Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis","volume":"43","author":"Mukerjee","year":"2004","journal-title":"Rheumatol Oxf"},{"key":"10.1016\/j.berh.2016.03.004_bib51","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","article-title":"Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"48","author":"Steen","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.03.004_bib52","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1002\/art.11345","article-title":"N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers","volume":"48","author":"Allanore","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.03.004_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/ar3876","article-title":"N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study","volume":"14","author":"Thakkar","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2016.03.004_bib54","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jacc.2003.09.051","article-title":"Clinical significance of brain natriuretic peptide in primary pulmonary hypertension","volume":"43","author":"Leuchte","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2016.03.004_bib55","doi-asserted-by":"crossref","first-page":"D73","DOI":"10.1016\/j.jacc.2013.10.034","article-title":"Treatment goals of pulmonary hypertension","volume":"62","author":"McLaughlin","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2016.03.004_bib56","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/eurheartj\/ehi891","article-title":"Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension","volume":"27","author":"Williams","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.berh.2016.03.004_bib57","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0954-6111(03)00254-3","article-title":"Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension","volume":"97","author":"Mukerjee","year":"2003","journal-title":"Respir Med"},{"key":"10.1016\/j.berh.2016.03.004_bib58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.HYP.0000170140.36633.8f","article-title":"Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP","volume":"46","author":"Luchner","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.berh.2016.03.004_bib59","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/imj.12890","article-title":"Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis","volume":"45","author":"Quinlivan","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/j.berh.2016.03.004_bib60","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/imj.12167","article-title":"Performance of screening algorithms in systemic sclerosis-related pulmonary arterial hypertension: a systematic review","volume":"43","author":"Thakkar","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.berh.2016.03.004_bib62","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00145608","article-title":"Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review","volume":"34","author":"Kovacs","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2016.03.004_bib63","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1378\/chest.14-0194","article-title":"Characterization of patients with borderline pulmonary arterial pressure","volume":"146","author":"Kovacs","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.berh.2016.03.004_bib64","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.37838","article-title":"Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension","volume":"65","author":"Valerio","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.03.004_bib65","first-page":"206","article-title":"Unilateral pulmonary artery occlusion in man; control studies","volume":"34","author":"Brofman","year":"1957","journal-title":"J\u00a0Thorac Surg"},{"key":"10.1016\/j.berh.2016.03.004_bib66","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jacc.2013.06.034","article-title":"Cor pulmonale revisited","volume":"62","author":"Rubin","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2016.03.004_bib67","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201211-2090CI","article-title":"Exercise-induced pulmonary hypertension: physiological basis and methodological concerns","volume":"187","author":"Naeije","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.berh.2016.03.004_bib68","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1183\/09031936.00021915","article-title":"Criteria for diagnosis of exercise pulmonary hypertension","volume":"46","author":"Herve","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2016.03.004_bib69","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1183\/09031936.00061015","article-title":"Exercise-induced pulmonary hypertension: at last!","volume":"46","author":"Naeije","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2016.03.004_bib70","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2009.120303","article-title":"Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group","volume":"69","author":"Avouac","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.03.004_bib71","article-title":"A\u00a0prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naive systemic sclerosis-associated pulmonary arterial hypertension","author":"Sanges","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.03.004_bib72","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N.\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2016.03.004_bib73","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1183\/13993003.00364-2015","article-title":"Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN","volume":"46","author":"Simonneau","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2016.03.004_bib74","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N.\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2016.03.004_bib75","doi-asserted-by":"crossref","unstructured":"Galie N, Muller K, Scalise AV, et\u00a0al: PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension. Eur Respir J. 2015; 45:1314\u20131322.","DOI":"10.1183\/09031936.00105914"},{"key":"10.1016\/j.berh.2016.03.004_bib76","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2016.03.004_bib77","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Galie","year":"2015","journal-title":"N.\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2016.03.004_bib78","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.201507-1398OC","article-title":"Ambrisentan and tadalafil up-front combination therapy in scleroderma-associated pulmonary arterial hypertension","volume":"192","author":"Hassoun","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.berh.2016.03.004_bib79","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1183\/09031936.00004414","article-title":"Validation of two predictive models for survival in pulmonary arterial hypertension","volume":"46","author":"Sitbon","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2016.03.004_bib80","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.rmed.2011.12.018","article-title":"Dual therapy in IPAH and SSc-PAH. A qualitative systematic review","volume":"106","author":"Johnson","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.berh.2016.03.004_bib81","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1183\/09031936.00116313","article-title":"Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study","volume":"43","author":"Sitbon","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2016.03.004_bib82","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3899\/jrheum.110765","article-title":"Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease","volume":"39","author":"Johnson","year":"2012","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.03.004_bib83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.113.004526","article-title":"Anticoagulation and survival in pulmonary arterial hypertension: results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)","volume":"129","author":"Olsson","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2016.03.004_bib84","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.115.018435","article-title":"Effect of warfarin treatment on survival of patients with pulmonary arterial hypertension (PAH) in the registry to evaluate early and long-term pah disease management (REVEAL)","volume":"132","author":"Preston","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2016.03.004_bib85","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/imj.12111","article-title":"Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?","volume":"43","author":"Nikpour","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.berh.2016.03.004_bib86","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1177\/0961203314552461","article-title":"Could pulmonary arterial hypertension be an active index of systemic lupus erythematosus? A successful case of SLE-PAH cured by methylprednisolone pulse therapy","volume":"23","author":"Huang","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2016.03.004_bib87","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/0961203311403347","article-title":"The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review","volume":"20","author":"Kato","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2016.03.004_bib88","first-page":"2668","article-title":"Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease","volume":"75","author":"Miyamichi-Yamamoto","year":"2011","journal-title":"Circ J Off J Jpn Circ Soc"},{"key":"10.1016\/j.berh.2016.03.004_bib89","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"Jais","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.03.004_bib90","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1177\/0961203307087610","article-title":"Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report","volume":"17","author":"Hennigan","year":"2008","journal-title":"Lupus"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694216300237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694216300237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T15:54:57Z","timestamp":1536681297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694216300237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1521694216300237"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2016.03.004","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Connective tissue disease-related pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2016.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}